ConductScience.org, home

Paper26626558

Future directions in the treatment of osteosarcoma.

Bishop MW and 2 others. Curr Opin Pediatr, 2016. Cited by 229 papers, by iCite.

Cite this record

ConductScience Library. Future directions in the treatment of osteosarcoma. Papers, record 26626558. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26626558

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Future directions in the treatment of osteosarcoma.
PubMed
Journal
Curr Opin Pediatr
PubMed
Year
2016
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
229
iCite
Relative citation ratio, by iCite
8.66
iCite
Revised in PubMed
2024-05-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bishop MWMichael W
2Janeway KAKatherine A
3Gorlick RRichard

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bone NeoplasmsMajor topic
ImmunotherapyMajor topic
Molecular Targeted TherapyMajor topic
OsteosarcomaMajor topic
Biomarkers, Tumor
Chemotherapy, Adjuvant
Child
Chromosome Aberrations
Genetic Predisposition to Disease
Humans
Karyotype
Prognosis

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 CA013330NCI NIH HHSUnited StatesP30CA013330PubMed and NIHNIH RePORTER
U01 CA199221NCI NIH HHSUnited StatesU01CA199221PubMed and NIHNIH RePORTER
UL1 TR001425NCATS NIH HHSUnited StatesUL1TR001425PubMed and NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT04890067Observational Study in Localized OsteosarcomaBackground

Source ClinicalTrials.gov

Download CSV of trials

References46

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118235123Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.J Clin Oncol2008https://conductscience.org/library/papers/18235123PubMed
223520471Wee1 inhibition by MK-1775 leads to tumor inhibition and enhances efficacy of gemcitabine in human sarcomas.PLoS One2013https://conductscience.org/library/papers/23520471PubMed
325765070Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer.Science2015https://conductscience.org/library/papers/25765070PubMed
425611047A summary of the osteosarcoma banking efforts: a report from the Children's Oncology Group and the QuadW Foundation.Pediatr Blood Cancer2015https://conductscience.org/library/papers/25611047PubMed
521529352WEE1 inhibition sensitizes osteosarcoma to radiotherapy.BMC Cancer2011https://conductscience.org/library/papers/21529352PubMed
623339462MicroRNA paraffin-based studies in osteosarcoma reveal reproducible independent prognostic profiles at 14q32.Genome Med2013https://conductscience.org/library/papers/23339462PubMed
725421877EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment.Ann Oncol2015https://conductscience.org/library/papers/25421877PubMed
825512523Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma.Proc Natl Acad Sci U S A2014https://conductscience.org/library/papers/25512523PubMed
925961939A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis.Nat Genet2015https://conductscience.org/library/papers/25961939PubMed
1025751499Enhanced T-cell immunity to osteosarcoma through antibody blockade of PD-1/PD-L1 interactions.J Immunother2015https://conductscience.org/library/papers/25751499PubMed
1112743156Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.J Clin Oncol2003https://conductscience.org/library/papers/12743156PubMed
1221527590A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study.Ann Oncol2012https://conductscience.org/library/papers/21527590PubMed
1324912408Initial testing (stage 1) of glembatumumab vedotin (CDX-011) by the pediatric preclinical testing program.Pediatr Blood Cancer2014https://conductscience.org/library/papers/24912408PubMed
1426305408Targeting Glycoprotein NMB With Antibody-Drug Conjugate, Glembatumumab Vedotin, for the Treatment of Osteosarcoma.Pediatr Blood Cancer2016https://conductscience.org/library/papers/26305408PubMed
1525409260Genetic basis for clinical response to CTLA-4 blockade in melanoma.N Engl J Med2014https://conductscience.org/library/papers/25409260PubMed
1623434734The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 upregulation in osteosarcoma preclinical models.Clin Cancer Res2013https://conductscience.org/library/papers/23434734PubMed
1724166473Ganglioside GD2 as a therapeutic target for antibody-mediated therapy in patients with osteosarcoma.Cancer2014https://conductscience.org/library/papers/24166473PubMed
1824866169Programmed cell death ligand 1 expression in osteosarcoma.Cancer Immunol Res2014https://conductscience.org/library/papers/24866169PubMed
1923311495MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma.Orphanet J Rare Dis2013https://conductscience.org/library/papers/23311495PubMed
2025642322Ganglioside GD2 expression is maintained upon recurrence in patients with osteosarcoma.Clin Sarcoma Res2015https://conductscience.org/library/papers/25642322PubMed

See all 46 referencesDownload CSV of references

Cited by173

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 229 citations.

PMIDTitleJournalYearIn PapersSource
42711706Phototherapy-responsive nanoplatform with hydrogel delivery potentiates immunotherapy and inhibits lung metastasis in osteosarcoma via synergistic glycolysis inhibition and vascular normalization.J Nanobiotechnology2026https://conductscience.org/library/papers/42711706PubMed
42403956FBXL5 depletion as a novel strategy against osteosarcoma: Evidence for MEK/ERK inhibition and enhanced therapeutic sensitivity.Oncol Lett2026https://conductscience.org/library/papers/42403956PubMed
42272640Heterogeneity-based stratification identifies CKMT2 as a prognostic marker in osteosarcoma.Front Cell Dev Biol2026https://conductscience.org/library/papers/42272640PubMed
41827906PROTAC-Mediated Targeted Degradation of MDM2 Induces Tumor-Suppressive Signaling in Osteosarcoma Cells.Cells2026https://conductscience.org/library/papers/41827906PubMed
41118012Pan-cancer analysis of role of LOXL4 and experiment validation in osteosarcoma.Discov Oncol2025https://conductscience.org/library/papers/41118012PubMed
41078460CXCL10-induced chemotaxis of ex vivo-expanded natural killer cells combined with NKTR-255 enhances anti-tumor efficacy in osteosarcoma.Mol Ther Oncol2025https://conductscience.org/library/papers/41078460PubMed
40599602The role and research progress of the MET signalling pathway in targeted therapy for osteosarcoma.Oncol Rev2025https://conductscience.org/library/papers/40599602PubMed
40534850Osteosarcoma immune microenvironment: cellular struggle and novel therapeutic insights.Front Immunol2025https://conductscience.org/library/papers/40534850PubMed
40512277Gambogic acid suppresses osteosarcoma progression through upregulation of FOXO3a.Discov Oncol2025https://conductscience.org/library/papers/40512277PubMed
39995821Bibliometric analysis of targeted immunotherapy for osteosarcoma-current knowledge, hotspots and future perspectives.Front Immunol2024https://conductscience.org/library/papers/39995821PubMed
39962461Integrated analysis of single-cell and bulk transcriptomics reveals cellular subtypes and molecular features associated with osteosarcoma prognosis.BMC Cancer2025https://conductscience.org/library/papers/39962461PubMed
39825088Integrins identified as potential prognostic markers in osteosarcoma through multi-omics and multi-dataset analysis.NPJ Precis Oncol2025https://conductscience.org/library/papers/39825088PubMed
39781890Inhibition of DKK-1 by WAY262611 Inhibits Osteosarcoma Metastasis.Mol Cancer Ther2025https://conductscience.org/library/papers/39781890PubMed
39727177LncRNA-associated ceRNA Network Revealing the Potential Regulatory Roles of Ferroptosis and Immune Infiltration in Osteosarcoma as well as Construction of the Prognostic Model.Curr Med Chem2025https://conductscience.org/library/papers/39727177PubMed
39590531Calcium Phosphate Loaded with Curcumin Prodrug and Selenium Is Bifunctional in Osteosarcoma Treatments.J Funct Biomater2024https://conductscience.org/library/papers/39590531PubMed
39015175LncRNAs as potential prognosis/diagnosis markers and factors driving drug resistance of osteosarcoma, a review.Front Endocrinol (Lausanne)2024https://conductscience.org/library/papers/39015175PubMed
38980440Investigation of prognostic values of immune infiltration and LGMN expression in the microenvironment of osteosarcoma.Discov Oncol2024https://conductscience.org/library/papers/38980440PubMed
38910902Hsa_circ_0064636 regulates voltage dependent anion channel 1/ubiquitination factor E4A through miR‑326/miR‑503‑5 in osteosarcoma.Oncol Lett2024https://conductscience.org/library/papers/38910902PubMed
38847977Neoadjuvant chemotherapy-induced hemoglobin decline as a prognostic factor in osteosarcoma around the knee joint: a single-center retrospective analysis of 242 patients.Support Care Cancer2024https://conductscience.org/library/papers/38847977PubMed
38769124Targeting the mitochondrial protein YME1L to inhibit osteosarcoma cell growth in vitro and in vivo.Cell Death Dis2024https://conductscience.org/library/papers/38769124PubMed

See all 173 cited byDownload CSV of cited by

Genes41

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ATR545PubTator's text mininghttps://conductscience.org/library/genes/545NCBI Gene
ATRX546PubTator's text mininghttps://conductscience.org/library/genes/546NCBI Gene
BRAF673PubTator's text mininghttps://conductscience.org/library/genes/673NCBI Gene
CHEK11111PubTator's text mininghttps://conductscience.org/library/genes/1111NCBI Gene
CSF11435PubTator's text mininghttps://conductscience.org/library/genes/1435NCBI Gene
DLG21740PubTator's text mininghttps://conductscience.org/library/genes/1740NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
FKBP1AP42285PubTator's text mininghttps://conductscience.org/library/genes/2285NCBI Gene
FLT32322PubTator's text mininghttps://conductscience.org/library/genes/2322NCBI Gene
GPNMB10457PubTator's text mininghttps://conductscience.org/library/genes/10457NCBI Gene
GRM42914PubTator's text mininghttps://conductscience.org/library/genes/2914NCBI Gene
KDR3791PubTator's text mininghttps://conductscience.org/library/genes/3791NCBI Gene
KIT3815PubTator's text mininghttps://conductscience.org/library/genes/3815NCBI Gene
MAPK15594PubTator's text mininghttps://conductscience.org/library/genes/5594NCBI Gene
MATK4145PubTator's text mininghttps://conductscience.org/library/genes/4145NCBI Gene
MDM24193PubTator's text mininghttps://conductscience.org/library/genes/4193NCBI Gene
MIR134406924PubTator's text mininghttps://conductscience.org/library/genes/406924NCBI Gene
MIR214406996PubTator's text mininghttps://conductscience.org/library/genes/406996NCBI Gene
MIR382494331PubTator's text mininghttps://conductscience.org/library/genes/494331NCBI Gene
MIR544A664613PubTator's text mininghttps://conductscience.org/library/genes/664613NCBI Gene

See all 41 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26626558

GET https://conductscience.org/api/papers/v1/26626558/references?page=2